Students in the GDDTP Program typically receive their first choice of residency programs, and at the most prestigious institutions. Past trainees have been extremely successful in a variety of positions in academic medicine. The majority have gone on to become university professors, department chairmen, division section chiefs, NIH administrators, and executives at pharmaceutical companies.

Some of the program's most notable alumni include:

Jeffrey Leiden, MD, PhD

Dr. Leiden is now Managing Director of the life-sciences venture-capital firm Clarus Ventures, investing in biopharmaceuticals and medical technology companies. Dr. Leiden was previously President of the Pharmaceutical Products group at Abbott Laboratories, with research interests on transcriptional mechanisms that regulate cardiovascular development and their use in gene therapy.

Val C. Sheffield, MD, PhD

Dr. Sheffield is Professor of Pediatrics and Ophthalmology at the University of Iowa, as well as a Howard Hughes Investigator and the Director, Division of Genetics, Children’s Hospital of Iowa. His research centers on identifying and understanding the function of genes causing hereditary blindness, congenital heart disease, and Bardet-Biedl syndrome, as well as other conditions such as glaucoma, macular degeneration and hereditary deafness.